Taiwan FDA registration d8a8e21392f4c409f0d3d0d1a9110d17

Vites High Sensitivity Troponin I Immunoassay Kit

TW: "維特司" 高敏感性肌鈣蛋白 I 免疫檢測試劑組
Taiwan flagTaiwan·Risk Class 2·ORTHO-CLINICAL DIAGNOSTICS·Registered Oct 22, 2024 – Oct 22, 2029Active
Registration details
Analysis ID
d8a8e21392f4c409f0d3d0d1a9110d17
Customs Code
DHA05603750701
Company information
Manufacturer Country
United Kingdom
Authorized Representative
DKSH TAIWAN LTD.
Product details
Intended Use
Quantitative determination of central troponin I (cTnI) in human serum and plasma (heparin) was performed using the Vitesus ECi/ECiQ/3600 immunodiagnostic analyzer and the Vitesus 5600/XT 7600 biochemical immunoassayer.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1215 Creatine phosphokinase/creatine kinase or isoenzyme testing system; A.1150 calibration
Import Information
Input;; QMS/QSD
Dates and status
Registration Date
Oct 22, 2024
Expiry Date
Oct 22, 2029
About this record

Access comprehensive regulatory information for Vites High Sensitivity Troponin I Immunoassay Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d8a8e21392f4c409f0d3d0d1a9110d17 and manufactured by ORTHO-CLINICAL DIAGNOSTICS. The authorized representative in Taiwan is DKSH TAIWAN LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices